ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research.

October 22, 2004

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

Rabson Replaces Berlin At Div. Of Biology, Diagnosis

February 14, 1975

Community Based Control Program Taking Final Shape

April 29, 1977

Shaky Start For FY11 Appropriations Cycle As Congress Feels Pressure to Cut Spending

June 4, 2010

NCI’s Goal To Increase Minority Participation In Trials, Sondik Says

May 5, 1995